Patent details

Basic Information

Publication number:

EP1663398

PCT Application Number:

PCT/IB/2004/002943

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047693411

PCT Publication Number:

WO/2005/025675

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS AND SEROTONIN / NORADRENALINE REUPTAKE INHIBITORS

French Title of Invention:

ASSOCIATIONS COMPRENANT DES LIGANDS ALPHA-2-DELTA ET DES INHIBITEURS DU RECAPTAGE DE LA SEROTONINE ET DE LA NORADRENALINE

German Title of Invention:

KOMBINATIONEN AUS ALPHA-2-DELTA LIGANDEN UND SEROTONIN / NORADRENALIN-WIEDERAUFNAHMEHEMMERN

SPC Number:

Dates

Filing date:

06/09/2004

Grant date:

25/11/2009

EP Publication Date:

25/11/2009

PCT Publication Date:

24/03/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2006

EP B1 Publication Date:

25/11/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/09/2010

Expiration date:

06/09/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/09/2004

 

 

Name:

Pfizer Inc.

Address:

150 East 42nd Street, New York, NY 10017, United States (US)

Name:

Pfizer Limited

Address:

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)

Inventor

1

Name:

WILLIAMS Richard Griffith

Address:

United Kingdom (GB)

2

Name:

FIELD Mark John

Address:

United Kingdom (GB)

3

Name:

DOOLEY David J.

Address:

United States (US)

Priority

Priority Number:

502556 P

Priority Date:

12/09/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 29/00;

Filing date	Document type	Number of pages